Em cada 5 novos pacientes 4 preferem a Amara View em relação à Quattro, com base no grau de restrição que sentem quando as usam.*
29% superior em conforto**
29% superior na vedação**
20% superior em estabilidade**
25% superior no ajuste total**
37% superior na aprência geral**
Deseja ver mais resultados?
*Philips-Respironics sponsored testing at seven contracted clinical sites for a 2 week X 2 week randomized crossover study with 64 patients new to CPAP. Each patient tried Amara View and either Quattro or AirFit F10. Mask order between the two mask was randomized. Mask comparison responses were collected after the second interval crossover. Statistical significance at 95% confidence,+/- 5% using a one-sample Bionomial Test comparing the observed proportion to a 50/50 split. Average comparisons using a 0 to 10 rating score Among participants expressing a preference of one mask over another; Quattro, p-value = .004
**Philips-Respironics sponsored testing at two contracted clinical sites. Ninety-five compliant Quattro patients rated Quattro and then Amara View after approximately 30 days. Statistical significance at 95% confidence, +/- 5% using paired t-test comparing averages of 0 to 10 rating scores; p-value < .001
